` Comparison: CC vs BAS - Alpha Spread

CC
vs
BAS

Over the past 12 months, CC has significantly outperformed BAS, delivering a return of +64% compared to the BAS's +13% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
CC
BAS
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

CC Intrinsic Value
36.71 USD
Undervaluation 42%
Intrinsic Value
Price $21.2
BAS Intrinsic Value
57.84 EUR
Undervaluation 9%
Intrinsic Value
Price €52.84
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
Chemours Co
NYSE:CC
21.2 USD
Basf Se
XETRA:BAS
52.84 EUR
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
CC, BAS

Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Chemours Co
Revenue
Basf Se
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
CC, BAS

Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Chemours Co
NYSE:CC
Basf Se
XETRA:BAS
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

CC
15.5%
BAS
23.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Chemours Co
Basf Se

Operating Margin

CC
-0.1%
BAS
4.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Chemours Co
Basf Se

Net Margin

CC
-6.6%
BAS
2.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Chemours Co
Basf Se

FCF Margin

CC
0.9%
BAS
2.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Chemours Co
Basf Se

ROE

CC
-90.4%
BAS
4.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Chemours Co
Basf Se

ROA

CC
-5.2%
BAS
2.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Chemours Co
Basf Se

ROIC

CC
-0.1%
BAS
2.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Chemours Co
Basf Se

ROCE

CC
-0.1%
BAS
4.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Chemours Co
Basf Se

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
CC, BAS

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
CC, BAS

Loading
CC
BAS
Difference
www.alphaspread.com

Performance By Year
CC, BAS

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare CC to other stocks
APD
Air Products and Chemicals Inc
More expensive
vs CC
SOL
Sasol Ltd
S
More expensive
vs CC
600989
Ningxia Baofeng Energy Group C...
More expensive
vs CC
OMN
Omnia Holdings Ltd
O
More expensive
vs CC
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett